Clinical trial Recruiting at 1 site Interventional Ages 75 and up

Intelligent in-home video monitoring plus telealarm vs telealarm alone to prevent falls at home

Official title: Superiority of Intelligent Video Surveillance + Telealarm Over Telealarm Alone in Elderly People at Risk of Falling

Run by Centre Hospitalier Universitaire, Amiens · NCT05875038 · Data updated 2026-11-12

This trial will test whether adding an intelligent in-home video monitoring system to a telealarm helps prevent dangerous falls and prolonged lying in people aged 75 and older returning home after geriatric care.

More Fall trials

Quick facts

Study typeInterventional
Ages75 Years and up
SexAll
Enrollment395 (estimated)
SponsorCentre Hospitalier Universitaire, Amiens
Academic / other
Locations1 site (Amiens, Picardie)
StatusRecruiting
StartedMay 16, 2023
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedSeptember 9, 2025
Trial IDNCT05875038 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 75 or older recently hospitalized in geriatric services with a recent fall, monopodal support under 5 seconds, able to consent, and returning to a home environment where installation is feasible.

Probably not a fit

People confined to bed or chair, those under legal protection, individuals without social security affiliation, or those living outside the installation/monitoring area are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional trial compares an intelligent video surveillance system (VA2CS) plus a standard telealarm with telealarm alone in frail older adults at high risk of falling. It enrolls patients aged 75 or older who are hospitalized in acute geriatric or rehabilitation services, have a recent history of falls and poor single-leg support (<5 seconds), and whose return home is considered complex. The intervention group has the automated video system installed in the home alongside the telealarm while the control group continues with telealarm only. Main outcomes include fall-related events, time spent lying after a fall, emergency responses, and downstream effects such as rehospitalization or institutionalization.

Why it matters

Potential benefit: If successful, the combined system could reduce undetected falls and time spent lying after a fall, lowering complications and helping frail older adults remain at home longer.

How similar studies have gone: Traditional telealarms have limited effectiveness and intelligent video surveillance for fall detection has shown promise in small or observational studies but lacks robust large randomized trial evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Person aged 75 years or more
* hospitalized in an acute geriatric service or in a geriatric or multipurpose rehabilitation care service
* If living alone: receiving at least one visit per day from a relative or professional
* Recent history of fall and monopodal support \< 5 seconds
* Able to give informed consent.
* Return home considered complex by the patient or their relatives due to the risk of falling at home.

Exclusion Criteria:

* Under legal protection
* Not affiliated to a social security system
* Confined to bed or chair

Where it's running

  • CHU Amiens Picardie
    Amiens, Picardie, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.